Knowledge

Pharmaceutical Research and Manufacturers of America

Source 📝

1341: 34: 451:
The Partnership for Prescription Assistance is a program by PhRMA and its member companies that connects patients in-need with information on low-cost and free prescription medication. PhRMA has in 2017 raised concerns over price increases for generic drugs out of patent by the company
1167: 538: 484:
In January 2018, the organization introduced the "Let's Talk About Cost" website, which made the argument that much of the cost of medication goes to middlemen unassociated with pharmaceutical companies.
521: 863: 1391: 510: 1386: 707: 425: 222:. Despite the role that patents have played in maintaining higher drug costs for public health programs across Africa, the organization worked to minimize the effect of the 172:. At the state level, the organization has lobbied to prevent price limits and greater price transparency for drugs. The organization claims that higher prices incentivize 1290: 937: 632: 223: 1361: 181: 1396: 1086: 500: 1366: 1276: 1222: 1401: 912: 894: 548: 533: 1381: 165: 570: 527: 1371: 185: 1142: 982: 778: 760: 732:
Brezis M (2008). "Big pharma and health care: unsolvable conflict of interests between private enterprise and public health".
1316: 1196: 680: 494: 840: 624: 999: 214:
The organization has also lobbied against lowering drug prices internationally. The most visible conflict has been over
516: 154:
in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in
813:"Intellectual property and global health: from corporate social responsibility to the access to knowledge movement" 597: 445: 759:
Almashat S, Preston C, Waterman T, Wolfe S, et al. (Public Citizen's Health Research Group) (December 2010).
654: 1376: 470:
In 2017, the organization had revenue of $ 455 million, $ 128 million of which was spent on lobbying activities.
505: 441: 448:, and PhRMA to encourage consumers to properly dispose of unused medicines to avoid harm to the environment. 421: 263: 1247: 761:"Rapidly increasing criminal and civil monetary penalties against the pharmaceutical industry: 1991 to 2010" 143: 457: 1018: 281:
Since 2015, the president of the organization has been Stephen J. Ubl. Previous leadership includes:
1119: 543: 453: 235: 208: 204: 173: 161: 474: 333: 196: 169: 151: 20: 238: 405: 357: 938:"MSF: TRIPS waiver must be urgently adopted despite WTO Ministerial Conference postponement" 1052: 385: 341: 337: 864:"The Life-Cycle of Transnational Issues: Lessons from the Access to Medicines Controversy" 8: 286: 200: 1340: 886: 832: 313: 282: 231: 539:
Pharmaceutical Inspection Convention and Pharmaceutical Inspection Co-operation Scheme
1060: 979: 890: 836: 786: 741: 267: 246: 242: 168:
for Medicare recipients, and filed lawsuits against the drug price provisions in the
147: 97: 60: 230:
should not prevent countries from dealing with public health crises and allowed for
878: 824: 155: 74: 1200: 986: 882: 708:"In Election Year, Drug Industry Spent Big To Temper Talk About High Drug Prices" 373: 369: 353: 321: 275: 227: 812: 655:"PhRMA Warns of Dire Consequences if Medicare Allowed to Negotiate Drug Prices" 602: 393: 349: 302: 274:, is chairman and Daniel O'Day, Chairman of the Board of Directors and CEO of 219: 828: 1355: 1064: 790: 429: 298: 1223:"Marathon gets the Shkreli treatment from industry after $ 89K drug dust up" 1168:"After AbbVie's exodus, Teva walks away from influential trade group PhRMA" 745: 464: 401: 294: 681:"How Big Pharma is fighting Biden's program to lower seniors' drug costs" 345: 1291:"High price tags for medicines are about to come under renewed pressure" 146:), formerly known as the Pharmaceutical Manufacturers Association, is a 478: 361: 192: 1199:. Pharmaceutical Research and Manufacturers of America. Archived from 810: 522:
International Federation of Pharmaceutical Manufacturers Associations
365: 177: 417: 397: 389: 290: 271: 64: 1317:"PhRMA launches new consumer-facing Let's Talk About Cost website" 473:
The organization has notably opposed market pricing strategies of
1277:"PhRMA spent nearly 10 times 2016's sum on advertising last year" 511:
European Federation of Pharmaceutical Industries and Associations
413: 409: 377: 329: 1000:"Pharmaceutical group shifts tone with new pick for president" 913:"Bill Gates, Big Pharma and entrenching the vaccine apartheid" 266:’s Global Portfolio Division, is chairman of the PhRMA board. 1036:
Julian Pecquet (July 14, 2010). "PhRMA picks new president".
381: 325: 317: 33: 758: 997: 467:
regarding pharmaceutical drug intellectual property rules.
215: 1392:
Medical and health organizations based in Washington, D.C.
1111: 955: 477:, deriding the firm as having a strategy "reflective of a 1346: 1334: 117: 1387:
Health industry trade groups based in the United States
160:
The organization has lobbied fiercely against allowing
625:"Pharmaceutical Research and Manufacturers of America" 571:"Pharmaceutical Research and Manufacturers of America" 297:, a former Republican congressman from Louisiana, and 1087:"AstraZeneca to leave leading U.S. drug lobby group" 1019:"Special Interests: Tauzin to Head Drug Trade Group" 195:
donations to right-wing advocacy groups such as the
136:
Pharmaceutical Research and Manufacturers of America
27:
Pharmaceutical Research and Manufacturers of America
595: 501:Association of the British Pharmaceutical Industry 1141:Payne, Daniel; Mahr, Krista (December 15, 2022). 1353: 811:Timmermann, Cristian; Henk van den Belt (2013). 1053:"John Horan, Former Chief of Merck, Dies at 90" 1035: 549:Portuguese Pharmaceutical Industry Association 534:Japan Pharmaceutical Manufacturers Association 440:SMARxT Disposal is a joint program run by the 19:"PhRMA" redirects here. For related uses, see 1362:Pharmaceutical companies of the United States 1016: 998:N.C. Alzenman and Dan Eggen (July 14, 2010). 779:"The Stealth Campaign to Kill Off Obamacare" 528:International Intellectual Property Alliance 1397:Lobbying organizations in the United States 589: 1339: 1191: 1189: 973: 180:exceeds that spent on research, including 32: 1140: 904: 725: 596:The Editorial Board (November 27, 2015). 176:, even though pharmaceutical spending on 1367:1958 establishments in the United States 1314: 1040:. Vol. 17, no. 81. p. 22. 245:, which would have reduced the price of 129:Pharmaceutical Manufacturers Association 1402:1958 establishments in Washington, D.C. 1186: 910: 776: 705: 1354: 1274: 731: 186:settlements in the billions of dollars 1270: 1268: 1050: 861: 495:Biotechnology Innovation Organization 1382:Pharmaceutical industry trade groups 1315:Campbell, Holly (January 24, 2018). 1275:Kanski, Alison (November 26, 2018). 1084: 991: 565: 563: 463:The company has advocated abroad in 1017:Judy Sarasohn (December 16, 2004). 911:Allison, Simon (January 30, 2021). 199:(which lobbied heavily against the 13: 1265: 1122:from the original on April 6, 2022 843:from the original on June 23, 2020 706:Hancock, Jay (December 18, 2017). 635:from the original on April 6, 2022 598:"Turn the Volume Down on Drug Ads" 517:Generic Pharmaceutical Association 234:. The organization also opposed a 14: 1413: 1372:Organizations established in 1958 1326: 1051:Segal, David (January 28, 2011). 560: 312:Current member companies include 446:American Pharmacists Association 1308: 1283: 1240: 1215: 1160: 1134: 1104: 1078: 1044: 1029: 1010: 948: 930: 855: 804: 777:Hancock, Jay (July 27, 2018). 770: 752: 699: 673: 647: 617: 506:Ethics in pharmaceutical sales 442:U.S. Fish and Wildlife Service 262:Ramona Sequeira, President of 150:representing companies in the 1: 1085:Fick, Maggie (May 16, 2023). 942:Doctors Without Borders - USA 862:Morin, Jean-Frederic (2011). 554: 422:Takeda Pharmaceutical Company 301:, former CEO and chairman of 268:Vasant (Vas) Narasimhan, M.D. 257: 252: 98:Vasant (Vas) Narasimhan, M.D. 883:10.1080/13600826.2011.553914 740:(2): 83–9, discussion 90–4. 191:PhRMA has given substantial 7: 488: 458:Duchenne muscular dystrophy 435: 426:Teva Pharmaceutical Company 10: 1418: 734:Isr J Psychiatry Relat Sci 307: 249:for low-income countries. 18: 985:January 27, 2011, at the 829:10.1007/s10991-013-9129-9 123: 113: 103: 91: 81: 70: 56: 48: 40: 31: 1143:"AbbVie exits the lobby" 544:Pharmaceutical marketing 454:Marathon Pharmaceuticals 236:World Trade Organization 209:Americans for Tax Reform 205:Americans for Prosperity 174:research and development 917:The Mail & Guardian 575:National Health Council 475:Valeant Pharmaceuticals 334:BioMarin Pharmaceutical 285:, formerly head of the 197:American Action Network 170:Inflation Reduction Act 152:pharmaceutical industry 1377:Life sciences industry 289:, a U.S. advocacy and 278:, is board treasurer. 239:TRIPS Agreement waiver 406:Otsuka Pharmaceutical 386:Johnson & Johnson 358:Eli Lilly and Company 184:that has resulted in 900:on December 6, 2018. 817:Liverpool Law Review 659:www.medpagetoday.com 342:Bristol Myers Squibb 338:Boehringer Ingelheim 1197:"Patient Resources" 1023:The Washington Post 1004:The Washington Post 685:The Washington Post 661:. September 8, 2021 287:Business Roundtable 232:compulsory licenses 201:Affordable Care Act 182:off-label promotion 28: 1174:. February 3, 2023 1057:The New York Times 783:The New York Times 577:. November 4, 2014 283:John J. Castellani 226:, which said that 26: 1203:on March 19, 2011 247:COVID-19 vaccines 243:COVID-19 pandemic 133: 132: 61:Trade association 1409: 1347:Official website 1343: 1338: 1337: 1335:Official website 1321: 1320: 1312: 1306: 1305: 1303: 1301: 1287: 1281: 1280: 1272: 1263: 1262: 1260: 1258: 1244: 1238: 1237: 1235: 1233: 1219: 1213: 1212: 1210: 1208: 1193: 1184: 1183: 1181: 1179: 1164: 1158: 1157: 1155: 1153: 1138: 1132: 1131: 1129: 1127: 1108: 1102: 1101: 1099: 1097: 1082: 1076: 1075: 1073: 1071: 1048: 1042: 1041: 1033: 1027: 1026: 1014: 1008: 1007: 995: 989: 977: 971: 970: 968: 966: 952: 946: 945: 934: 928: 927: 925: 923: 908: 902: 901: 899: 893:. Archived from 868: 859: 853: 852: 850: 848: 808: 802: 801: 799: 797: 774: 768: 767: 765: 756: 750: 749: 729: 723: 722: 720: 718: 703: 697: 696: 694: 692: 687:. March 11, 2024 677: 671: 670: 668: 666: 651: 645: 644: 642: 640: 621: 615: 614: 612: 610: 593: 587: 586: 584: 582: 567: 224:Doha Declaration 156:Washington, D.C. 145: 118:Official website 75:Washington, D.C. 36: 29: 25: 1417: 1416: 1412: 1411: 1410: 1408: 1407: 1406: 1352: 1351: 1333: 1332: 1329: 1324: 1313: 1309: 1299: 1297: 1289: 1288: 1284: 1273: 1266: 1256: 1254: 1246: 1245: 1241: 1231: 1229: 1221: 1220: 1216: 1206: 1204: 1195: 1194: 1187: 1177: 1175: 1166: 1165: 1161: 1151: 1149: 1139: 1135: 1125: 1123: 1110: 1109: 1105: 1095: 1093: 1083: 1079: 1069: 1067: 1049: 1045: 1034: 1030: 1015: 1011: 996: 992: 987:Wayback Machine 978: 974: 964: 962: 954: 953: 949: 936: 935: 931: 921: 919: 909: 905: 897: 866: 860: 856: 846: 844: 809: 805: 795: 793: 775: 771: 763: 757: 753: 730: 726: 716: 714: 704: 700: 690: 688: 679: 678: 674: 664: 662: 653: 652: 648: 638: 636: 623: 622: 618: 608: 606: 594: 590: 580: 578: 569: 568: 561: 557: 491: 438: 394:Merck & Co. 374:GlaxoSmithKline 370:Gilead Sciences 322:Astellas Pharma 310: 303:Merck & Co. 276:Gilead Sciences 260: 255: 126: 125:Formerly called 106: 94: 87:Ramona Sequeira 84: 63: 24: 17: 12: 11: 5: 1415: 1405: 1404: 1399: 1394: 1389: 1384: 1379: 1374: 1369: 1364: 1350: 1349: 1344: 1328: 1327:External links 1325: 1323: 1322: 1307: 1282: 1264: 1248:"Leaky pharma" 1239: 1214: 1185: 1159: 1133: 1103: 1077: 1043: 1028: 1025:. p. A35. 1009: 990: 980:whorunsgov.com 972: 947: 929: 903: 877:(2): 227–247. 871:Global Society 854: 803: 769: 751: 724: 698: 672: 646: 616: 603:New York Times 588: 558: 556: 553: 552: 551: 546: 541: 536: 531: 525: 519: 514: 508: 503: 498: 490: 487: 437: 434: 350:Daiichi Sankyo 309: 306: 259: 256: 254: 251: 131: 130: 127: 124: 121: 120: 115: 111: 110: 109:Stephen J. Ubl 107: 104: 101: 100: 95: 92: 89: 88: 85: 82: 79: 78: 72: 68: 67: 58: 54: 53: 50: 46: 45: 42: 38: 37: 15: 9: 6: 4: 3: 2: 1414: 1403: 1400: 1398: 1395: 1393: 1390: 1388: 1385: 1383: 1380: 1378: 1375: 1373: 1370: 1368: 1365: 1363: 1360: 1359: 1357: 1348: 1345: 1342: 1336: 1331: 1330: 1318: 1311: 1296: 1295:The Economist 1292: 1286: 1278: 1271: 1269: 1253: 1252:The Economist 1249: 1243: 1228: 1224: 1218: 1202: 1198: 1192: 1190: 1173: 1172:Fierce Pharma 1169: 1163: 1148: 1144: 1137: 1121: 1117: 1113: 1107: 1092: 1088: 1081: 1066: 1062: 1058: 1054: 1047: 1039: 1032: 1024: 1020: 1013: 1005: 1001: 994: 988: 984: 981: 976: 961: 957: 951: 943: 939: 933: 918: 914: 907: 896: 892: 888: 884: 880: 876: 872: 865: 858: 842: 838: 834: 830: 826: 822: 818: 814: 807: 792: 788: 784: 780: 773: 762: 755: 747: 743: 739: 735: 728: 713: 709: 702: 686: 682: 676: 660: 656: 650: 634: 630: 626: 620: 605: 604: 599: 592: 576: 572: 566: 564: 559: 550: 547: 545: 542: 540: 537: 535: 532: 529: 526: 523: 520: 518: 515: 512: 509: 507: 504: 502: 499: 496: 493: 492: 486: 482: 480: 476: 471: 468: 466: 461: 459: 455: 449: 447: 443: 433: 431: 427: 423: 419: 415: 411: 407: 403: 399: 395: 391: 387: 383: 379: 375: 371: 367: 363: 359: 355: 351: 347: 343: 339: 335: 331: 327: 323: 319: 315: 305: 304: 300: 299:John J. Horan 296: 292: 288: 284: 279: 277: 273: 269: 265: 250: 248: 244: 240: 237: 233: 229: 225: 221: 217: 212: 210: 206: 202: 198: 194: 189: 187: 183: 179: 175: 171: 167: 164:to negotiate 163: 158: 157: 153: 149: 142:, pronounced 141: 137: 128: 122: 119: 116: 112: 108: 102: 99: 96: 90: 86: 80: 76: 73: 69: 66: 62: 59: 55: 51: 47: 43: 39: 35: 30: 22: 1310: 1300:February 12, 1298:. Retrieved 1294: 1285: 1257:February 12, 1255:. Retrieved 1251: 1242: 1232:February 18, 1230:. Retrieved 1227:Ars Technica 1226: 1217: 1205:. Retrieved 1201:the original 1176:. Retrieved 1171: 1162: 1150:. Retrieved 1146: 1136: 1124:. Retrieved 1115: 1106: 1094:. Retrieved 1090: 1080: 1068:. Retrieved 1056: 1046: 1037: 1031: 1022: 1012: 1003: 993: 975: 963:. Retrieved 959: 950: 941: 932: 920:. Retrieved 916: 906: 895:the original 874: 870: 857: 845:. Retrieved 823:(1): 47–73. 820: 816: 806: 794:. Retrieved 782: 772: 754: 737: 733: 727: 715:. Retrieved 711: 701: 689:. Retrieved 684: 675: 663:. Retrieved 658: 649: 637:. Retrieved 628: 619: 609:November 27, 607:. Retrieved 601: 591: 581:December 11, 579:. Retrieved 574: 483: 472: 469: 465:South Africa 462: 450: 439: 402:Novo Nordisk 311: 295:Billy Tauzin 280: 261: 213: 190: 159: 139: 135: 134: 71:Headquarters 41:Abbreviation 1178:February 9, 1152:February 9, 965:February 9, 847:October 31, 460:treatment. 346:CSL Behring 241:during the 166:drug prices 148:trade group 93:Board Chair 83:Board Chair 16:Trade group 1356:Categories 922:January 2, 796:October 3, 717:October 3, 665:October 3, 555:References 479:hedge fund 362:EMD Serono 258:Leadership 253:Membership 193:dark money 1065:0362-4331 960:phrma.org 891:216592972 837:145492036 791:0362-4331 691:March 13, 366:Genentech 270:, CEO of 218:drugs in 178:marketing 105:President 49:Formation 1207:April 6, 1147:POLITICO 1126:April 6, 1120:Archived 1070:June 28, 1038:The Hill 983:Archived 841:Archived 746:18982834 639:April 6, 633:Archived 489:See also 436:Programs 418:Sunovion 398:Novartis 390:Lundbeck 314:Alkermes 291:lobbying 272:Novartis 162:Medicare 144:/ˈfɑrmə/ 65:Lobbying 1112:"About" 1096:May 17, 1091:Reuters 956:"About" 524:(IFPMA) 513:(EFPIA) 308:Members 293:group, 114:Website 57:Purpose 1063:  889:  835:  789:  744:  629:C-SPAN 530:(IIPA) 444:, the 414:Sanofi 410:Pfizer 378:Incyte 330:Biogen 264:Takeda 220:Africa 207:, and 77:, U.S. 21:Pharma 1116:PhRMA 898:(PDF) 887:S2CID 867:(PDF) 833:S2CID 764:(PDF) 497:(BIO) 456:over 382:Ipsen 354:Eisai 326:Bayer 318:Amgen 228:TRIPS 140:PhRMA 44:PhRMA 1302:2018 1259:2018 1234:2017 1209:2011 1180:2023 1154:2023 1128:2022 1098:2023 1072:2022 1061:ISSN 967:2023 924:2022 849:2020 798:2021 787:ISSN 742:PMID 719:2021 693:2024 667:2021 641:2022 611:2015 583:2017 428:and 216:AIDS 52:1958 879:doi 825:doi 712:NPR 481:". 430:UCB 203:), 1358:: 1293:. 1267:^ 1250:. 1225:. 1188:^ 1170:. 1145:. 1118:. 1114:. 1089:. 1059:. 1055:. 1021:. 1002:. 958:. 940:. 915:. 885:. 875:25 873:. 869:. 839:. 831:. 821:34 819:. 815:. 785:. 781:. 738:45 736:. 710:. 683:. 657:. 631:. 627:. 600:. 573:. 562:^ 432:. 424:, 420:, 416:, 412:, 408:, 404:, 400:, 396:, 392:, 388:, 384:, 380:, 376:, 372:, 368:, 364:, 360:, 356:, 352:, 348:, 344:, 340:, 336:, 332:, 328:, 324:, 320:, 316:, 211:. 188:. 1319:. 1304:. 1279:. 1261:. 1236:. 1211:. 1182:. 1156:. 1130:. 1100:. 1074:. 1006:. 969:. 944:. 926:. 881:: 851:. 827:: 800:. 766:. 748:. 721:. 695:. 669:. 643:. 613:. 585:. 138:( 23:.

Index

Pharma

Trade association
Lobbying
Washington, D.C.
Vasant (Vas) Narasimhan, M.D.
Official website
trade group
pharmaceutical industry
Washington, D.C.
Medicare
drug prices
Inflation Reduction Act
research and development
marketing
off-label promotion
settlements in the billions of dollars
dark money
American Action Network
Affordable Care Act
Americans for Prosperity
Americans for Tax Reform
AIDS
Africa
Doha Declaration
TRIPS
compulsory licenses
World Trade Organization
TRIPS Agreement waiver
COVID-19 pandemic

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.